Why the study?
Does primary percutaneous coronary intervention or thrombolytic therapy reduce early and late mortality in patients with acute right ventricular infarction compared to no reperfusion therapy?
Does primary percutaneous coronary intervention or thrombolytic therapy reduce early and late mortality in patients with acute right ventricular infarction compared to no reperfusion therapy?
Primary percutaneous coronary intervention is superior to thrombolytic therapy and significantly reduces both short- and long-term mortality across all severity classes of acute right ventricular infarction, particularly in those with cardiogenic shock.
No takes yet. Share an insight, caveat, or question.
May support PPCI preference over thrombolysis in RVI; leaves open RCTs to confirm before practice change.
Eulo Lupi‐Herrera (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: